Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
about
Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital settingArginine catabolic mobile element encoded speG abrogates the unique hypersensitivity of Staphylococcus aureus to exogenous polyaminesAdult vaccinationModelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureusMRSA prevention and control in county correctional facilities in Southwestern Ohio.The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review.Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agentRevisiting Methicillin-Resistant Staphylococcus aureus Infections.Infection control link nurse program: an interdisciplinary approach in targeting health care-acquired infectionChanging epidemiology of methicillin-resistant Staphylococcus aureus in Iceland from 2000 to 2008: a challenge to current guidelines.Trimethoprim-sulfamethoxazole for methicillin-resistant Staphylococcus aureus: a forgotten alternative?Methicillin-resistant Staphylococcus aureus in Saarland, Germany: a statewide admission prevalence screening studyA retrospective study of risk factors for poor outcomes in methicillin-resistant Staphylococcus aureus (MRSA) infection in surgical patients.An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA)Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions.Resistance to ocular antibiotics: an overview.Optical fingerprinting in bacterial epidemiology: Raman spectroscopy as a real-time typing method.Economics of antibiotic resistance.Fact or infection: do surgical trainees know enough about infection control?Understanding the culture of antimicrobial prescribing in agriculture: a qualitative study of UK pig veterinary surgeons.Current methodologies for proteomics of bacterial surface-exposed and cell envelope proteins.Economic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus.Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA.The Impact of a Universal Decolonization Protocol on Hospital-Acquired Methicillin-Resistant Staphylococcus aureus in a Burn Population.Burden of antimicrobial resistance in an era of decreasing susceptibility.Implementing the MRSA recommendations made by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) of 1999 - current considerations by the DGKH Management Board.Restoration of susceptibility of methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics by acidic pH: role of penicillin-binding protein PBP 2a.Rapid screening for carriage of methicillin-resistant Staphylococcus aureus by PCR and associated costs.Characterization of Resistance to Aminoglycosides in Methicillin-Resistant Staphylococcus aureus Strains Isolated From a Tertiary Care Hospital in Tehran, Iran.On the economic impact of a regional management of multidrug-resistant bacteria.Novel adjuvant strategy to potentiate bacitracin against MDR MRSA.Antibiotic resistance and molecular epidemiology of methicillin-resistant Staphylococcus aureus from lower respiratory tract: multi-resistance and high prevalence of SCCmec III type.One-day point prevalence of emerging bacterial pathogens in a nationwide sample of 62 German hospitals in 2012 and comparison with the results of the one-day point prevalence of 2010Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand.Proposal for common Nordic epidemiological terms and definitions for methicillin-resistant Staphylococcus aureus (MRSA).Assessment of the Public Health significance of meticillin resistant Staphylococcus aureus (MRSA) in animals and foodsEconomic burden of nosocomial infections caused by vancomycin-resistant enterococci.Prevalence of methicillin-resistant Staphylococcus aureus in ambulances in southern Maine.Duration of methicillin-resistant Staphylococcus aureus colonization after diagnosis: a four-year experience from southern Sweden.
P2860
Q24186422-6EA2D0B9-01E2-4986-8031-C7E1B56F99E9Q24635354-7A8ECD1F-9ACB-47F7-8762-43E46B7A3C0DQ26824961-413C8AD5-9200-45FD-BB05-1C358AFD4CA8Q28741476-2F31FD99-0F06-4FA6-80AF-92640B4F274DQ30227765-A4AFB37A-454D-465F-BD41-7D5E5049AE15Q33336677-17E617AC-87BE-46F3-935C-46B389A445B4Q33508694-98D190FE-6A55-4539-A4F4-CFC1B4A39178Q33736523-B9D5E4C6-D996-4FFB-B7C0-3A9CBBF51E8FQ33926179-682F4F11-20D1-4A79-8634-242EAD1C164FQ34489712-A745B52C-3428-43AB-A6FD-6B6074139F8EQ34979705-AD85B0BF-BFA7-4A34-B56A-D516F76A5C31Q34989450-4A7C08A4-CE4C-4662-85B6-173C9D5BB1DBQ35061275-CF80A7D8-73BB-430A-B511-5425E7BE1B2BQ35973180-94C492C3-B265-4F0F-8CFA-7258E71A295FQ36758570-7D8F4FCB-D201-47E8-B057-92143D9F7E5BQ36834425-4F604550-0C0A-4E5A-B45E-DD1EFCE132F8Q37116744-CA1C12C9-D2F5-4AA8-929B-BC3A613CE974Q37228745-CB45DE7D-49FC-4C33-982F-001BA78A3CE0Q37307628-35869D98-495D-47FE-B150-0D599E5D9EF3Q37364905-EDF00CA5-CF43-4D77-890E-16DD411C6774Q37897206-23C012A5-D8D1-4E8B-8813-8EE870BBA645Q38275128-D6F88937-E8C0-412C-A76E-DFBC7A5855EBQ39164183-C0AF0616-7DFD-48E9-93A2-EE828702B5F7Q39201539-E4BEC089-4A9C-437F-9547-9CF5468F7CEEQ39350575-A739BBC0-2CFA-464D-9859-F2C451EC43E4Q39380350-59C25731-109B-4F32-9061-2367E7D965B0Q39648311-A985F293-EB0C-49D4-A554-BD2946D7DD00Q39762193-C0280122-60C5-4801-A7B2-F8F2E1C3D442Q39834901-5191B193-801D-4AC5-902C-EE7099D8AFC8Q40207064-00B6B40F-708B-4869-9B4A-1D4EB54E15BBQ40827493-111132FE-2D46-44E7-9C42-7CB88E62734BQ42272733-106205C1-1D4E-4368-BEDB-8FC2EE5364B4Q42559504-55F79CAB-904C-4C59-8BB4-55D1CD887A38Q43149693-2712CFC6-A756-4792-A07A-7C1A6CE73C64Q44029839-1A632E62-C0FE-4DE2-8EB8-9225130FAAFBQ46515391-508095C2-5EA7-4432-ABEE-5C45D8895C02Q47146467-BD1168DD-71D9-4D12-8523-AC559D49332DQ47178117-9898C13B-3027-409D-A2E5-4E9C148822F5Q47806385-F50B93D5-EC05-43EC-BD9B-21652D1B5694Q50787869-6EE3D580-CB66-4134-A25D-138E3B3BBBBE
P2860
Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Costs of hospital-acquired met ...... aureus (MRSA) and its control.
@ast
Costs of hospital-acquired met ...... aureus (MRSA) and its control.
@en
type
label
Costs of hospital-acquired met ...... aureus (MRSA) and its control.
@ast
Costs of hospital-acquired met ...... aureus (MRSA) and its control.
@en
prefLabel
Costs of hospital-acquired met ...... aureus (MRSA) and its control.
@ast
Costs of hospital-acquired met ...... aureus (MRSA) and its control.
@en
P1476
Costs of hospital-acquired met ...... aureus (MRSA) and its control.
@en
P2093
P304
P356
10.1016/J.IJANTIMICAG.2006.09.001
P577
2006-10-11T00:00:00Z